Punch & Associates Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-81,316
| Closed | -$4.8M | – | 172 |
|
|
2024
Q2 | $4.8M | Buy |
81,316
+70
| +0.1% | +$4.38K | 0.28% | 123 |
|
|
2024
Q1 | $6.48M | Sell |
81,246
-2,217
| -3% | -$169K | 0.37% | 113 |
|
|
2023
Q4 | $6.59M | Sell |
83,463
-1,414
| -2% | -$101K | 0.39% | 109 |
|
|
2023
Q3 | $5.93M | Buy |
84,877
+547
| +0.6% | +$38.8K | 0.38% | 113 |
|
|
2023
Q2 | $5.83M | Sell |
84,330
-683
| -0.8% | -$48.6K | 0.36% | 112 |
|
|
2023
Q1 | $6.32M | Sell |
85,013
-375
| -0.4% | -$31.4K | 0.41% | 107 |
|
|
2022
Q4 | $7.96M | Buy |
85,388
+347
| +0.4% | +$33.5K | 0.52% | 83 |
|
|
2022
Q3 | $8.11M | Buy |
85,041
+878
| +1% | +$86.9K | 0.57% | 67 |
|
|
2022
Q2 | $7.8M | Sell |
84,163
-495
| -0.6% | -$48.3K | 0.55% | 77 |
|
|
2022
Q1 | $8.57M | Buy |
84,658
+2,961
| +4% | +$311K | 0.49% | 94 |
|
|
2021
Q4 | $8.43M | Buy |
81,697
+9,382
| +13% | +$867K | 0.44% | 96 |
|
|
2021
Q3 | $6.14M | Buy |
72,315
+7,061
| +11% | +$591K | 0.35% | 120 |
|
|
2021
Q2 | $5.45M | Buy |
65,254
+177
| +0.3% | +$14.5K | 0.31% | 126 |
|
|
2021
Q1 | $4.9M | Buy |
65,077
+867
| +1% | +$63.2K | 0.29% | 130 |
|
|
2020
Q4 | $4.39M | Sell |
64,210
-1,597
| -2% | -$104K | 0.31% | 125 |
|
|
2020
Q3 | $3.84M | Sell |
65,807
-598
| -0.9% | -$37.2K | 0.33% | 120 |
|
|
2020
Q2 | $4.31M | Buy |
66,405
+7,263
| +12% | +$457K | 0.39% | 101 |
|
|
2020
Q1 | $3.51M | Buy |
59,142
+1,091
| +2% | +$72.8K | 0.42% | 95 |
|
|
2019
Q4 | $4.31M | Sell |
58,051
-1,210
| -2% | -$85K | 0.34% | 114 |
|
|
2019
Q3 | $3.74M | Buy |
59,261
+289
| +0.5% | +$17.1K | 0.31% | 125 |
|
|
2019
Q2 | $3.21M | Buy |
58,972
+788
| +1% | +$42.4K | 0.27% | 134 |
|
|
2019
Q1 | $3.14M | Buy |
58,184
+1,460
| +3% | +$90.1K | 0.27% | 143 |
|
|
2018
Q4 | $3.72M | Sell |
56,724
-313
| -0.5% | -$23.4K | 0.36% | 120 |
|
|
2018
Q3 | $4.49M | Buy |
57,037
+3,425
| +6% | +$245K | 0.36% | 115 |
|
|
2018
Q2 | $3.45M | Sell |
53,612
-410
| -0.8% | -$27K | 0.28% | 135 |
|
|
2018
Q1 | $3.36M | Sell |
54,022
-843
| -2% | -$60.5K | 0.3% | 133 |
|
|
2017
Q4 | $3.98M | Sell |
54,865
-450
| -0.8% | -$32.7K | 0.34% | 121 |
|
|
2017
Q3 | $4.5M | Sell |
55,315
-428
| -0.8% | -$33.9K | 0.4% | 109 |
|
|
2017
Q2 | $4.49M | Sell |
55,743
-840
| -1% | -$66.3K | 0.42% | 106 |
|
|
2017
Q1 | $4.44M | Buy |
56,583
+1,180
| +2% | +$94.2K | 0.43% | 104 |
|
|
2016
Q4 | $4.37M | Sell |
55,403
-110
| -0.2% | -$8.9K | 0.43% | 100 |
|
|
2016
Q3 | $4.94M | Buy |
55,513
+827
| +2% | +$78.1K | 0.53% | 72 |
|
|
2016
Q2 | $5.24M | Buy |
54,686
+841
| +2% | +$83.8K | 0.61% | 60 |
|
|
2016
Q1 | $5.58M | Sell |
53,845
-1,911
| -3% | -$186K | 0.68% | 56 |
|
|
2015
Q4 | $5.45M | Buy |
55,756
+6,547
| +13% | +$641K | 0.66% | 57 |
|
|
2015
Q3 | $4.75M | Buy |
49,209
+1,129
| +2% | +$119K | 0.65% | 58 |
|
|
2015
Q2 | $5.04M | Buy |
48,080
+166
| +0.3% | +$17K | 0.63% | 62 |
|
|
2015
Q1 | $4.95M | Sell |
47,914
-9,509
| -17% | -$962K | 0.62% | 65 |
|
|
2014
Q4 | $5.53M | Sell |
57,423
-818
| -1% | -$72.1K | 0.71% | 50 |
|
|
2014
Q3 | $4.63M | Sell |
58,241
-276
| -0.5% | -$21.8K | 0.65% | 60 |
|
|
2014
Q2 | $4.41M | Buy |
58,517
+24
| +0% | +$1.81K | 0.59% | 63 |
|
|
2014
Q1 | $4.38M | Sell |
58,493
-660
| -1% | -$46.6K | 0.6% | 64 |
|
|
2013
Q4 | $4.23M | Sell |
59,153
-889
| -1% | -$57.1K | 0.57% | 71 |
|
|
2013
Q3 | $3.41M | Sell |
60,042
-952
| -2% | -$56.7K | 0.53% | 82 |
|
|
2013
Q2 | $3.49M | Buy |
+60,994
| New | +$3.53M | 0.61% | 64 |
|
Other funds holding CVS
Punch & Associates Investment Management's CVS Position: Q3 2024 in Review
Punch & Associates Investment Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 81,316 shares — an estimated $4.8M sold.
Punch & Associates Investment Management first reported a position in CVS in Q2 2013 and held it in 45 quarters. The position peaked at $8.57M in Q1 2022. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Punch & Associates Investment Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Punch & Associates Investment Management sold 81,316 CVS Health shares in Q3 2024, an estimated $4.8M.
- Punch & Associates Investment Management first reported a position in CVS Health in Q2 2013 and held it in 45 quarters.
- Punch & Associates Investment Management's CVS Health position peaked at $8.57M in Q1 2022.
- 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Punch & Associates Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.